India’s drug pricing authority on Wednesday imposed profit-margin caps on 42 anti-cancer medicines, but drew criticism from sections of patients’ rights activists who said the move would have limi...

The retail prices of more than 150 formulations of cancer drugs in India will fall by 50 per cent or higher under price caps on 42 anti-cancer medications announced last month, India’s drug pricing ...

The 30 per cent cap on profit margins imposed by India’s drug pricing authority on 42 anti-cancer drugs will have a limited impact on patients’ expenses because many of these medicines’ prices r...